These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 1646001)
41. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells. Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033 [TBL] [Abstract][Full Text] [Related]
42. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. D'Arpa P; Beardmore C; Liu LF Cancer Res; 1990 Nov; 50(21):6919-24. PubMed ID: 1698546 [TBL] [Abstract][Full Text] [Related]
43. Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase II. Robinson MJ; Osheroff N Biochemistry; 1991 Feb; 30(7):1807-13. PubMed ID: 1847075 [TBL] [Abstract][Full Text] [Related]
44. In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatin. Yang L; Rowe TC; Nelson EM; Liu LF Cell; 1985 May; 41(1):127-32. PubMed ID: 2986841 [TBL] [Abstract][Full Text] [Related]
45. Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II. Robinson MJ; Corbett AH; Osheroff N Biochemistry; 1993 Apr; 32(14):3638-43. PubMed ID: 8385484 [TBL] [Abstract][Full Text] [Related]
46. Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II. Minford J; Pommier Y; Filipski J; Kohn KW; Kerrigan D; Mattern M; Michaels S; Schwartz R; Zwelling LA Biochemistry; 1986 Jan; 25(1):9-16. PubMed ID: 3006754 [TBL] [Abstract][Full Text] [Related]
47. Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei. Pommier Y; Schwartz RE; Zwelling LA; Kohn KW Biochemistry; 1985 Nov; 24(23):6406-10. PubMed ID: 3002439 [TBL] [Abstract][Full Text] [Related]
48. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage. Marx G; Zhou H; Graves DE; Osheroff N Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321 [TBL] [Abstract][Full Text] [Related]
49. Effect of CPT on the calf thymus Topoisomerase I-mediated DNA breakage-reunion reaction: optimal conditions for the formation and reversal of the CPT trapped Topoisomerase I cleavable complex. Coderoni S; Paparelli M; Gianfranceschi GL Mol Biol Rep; 1993 Feb; 17(2):129-34. PubMed ID: 8384692 [TBL] [Abstract][Full Text] [Related]
50. Induction of cleavage in topoisomerase I c-DNA by topoisomerase I enzymes from calf thymus and wheat germ in the presence and absence of camptothecin. Tanizawa A; Kohn KW; Pommier Y Nucleic Acids Res; 1993 Nov; 21(22):5157-66. PubMed ID: 8255771 [TBL] [Abstract][Full Text] [Related]
51. Progressive resistance to doxorubicin in mouse leukemia L1210 cells with multidrug resistance phenotype: reductions in drug-induced topoisomerase II-mediated DNA cleavage. Ganapathi R; Grabowski D; Ford J; Heiss C; Kerrigan D; Pommier Y Cancer Commun; 1989; 1(4):217-24. PubMed ID: 2576973 [TBL] [Abstract][Full Text] [Related]
52. Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine. Kim SA; Kwon Y; Kim JH; Muller MT; Chung IK Biochemistry; 1998 Nov; 37(46):16316-24. PubMed ID: 9819224 [TBL] [Abstract][Full Text] [Related]
53. Antitumor activity of ER-37328, a novel carbazole topoisomerase II inhibitor. Nakamura K; Sugumi H; Yamaguchi A; Uenaka T; Kotake Y; Okada T; Kamata J; Niijima J; Nagasu T; Koyanagi N; Yoshino H; Kitoh K; Yoshimatsu K Mol Cancer Ther; 2002 Jan; 1(3):169-75. PubMed ID: 12467211 [TBL] [Abstract][Full Text] [Related]
54. Distinct patterns of cell cycle disturbance elicited by compounds interfering with DNA topoisomerase I and II activity. Poot M; Hiller KH; Heimpel S; Hoehn H Exp Cell Res; 1995 May; 218(1):326-30. PubMed ID: 7537696 [TBL] [Abstract][Full Text] [Related]
55. Mutations of the bacteriophage T4 type II DNA topoisomerase that alter sensitivity to antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide and an antibacterial quinolone. Freudenreich CH; Chang C; Kreuzer KN Cancer Res; 1998 Mar; 58(6):1260-7. PubMed ID: 9515814 [TBL] [Abstract][Full Text] [Related]
56. A camptothecin-resistant DNA topoisomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons. Knab AM; Fertala J; Bjornsti MA J Biol Chem; 1995 Mar; 270(11):6141-8. PubMed ID: 7890748 [TBL] [Abstract][Full Text] [Related]
57. Analysis of the DNA topoisomerase-II-mediated cleavage of the long terminal repeat of Drosophila 1731 retrotransposon. Nahon E; Best-Belpomme M; Saucier JM Eur J Biochem; 1993 Nov; 218(1):95-102. PubMed ID: 8243480 [TBL] [Abstract][Full Text] [Related]
58. Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials. Poddevin B; Riou JF; Lavelle F; Pommier Y Mol Pharmacol; 1993 Oct; 44(4):767-74. PubMed ID: 8232227 [TBL] [Abstract][Full Text] [Related]
59. Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells. Lelièvre S; Benchokroun Y; Larsen AK Mol Pharmacol; 1995 May; 47(5):898-906. PubMed ID: 7746278 [TBL] [Abstract][Full Text] [Related]
60. Intercalator-induced, topoisomerase II-mediated DNA cleavage and its modification by antineoplastic antimetabolites. Zwelling LA; Silberman L; Estey E Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1041-7. PubMed ID: 2427489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]